Melanoma, Secondary cancers, Skin cancer
Results
Phase 1/2
This trial looked at 2 drugs called trametinib and pazopanib with paclitaxel chemotherapy in melanoma skin cancer.
It was for people whose melanoma:
had spread to nearby or spread elsewhere in the body (advanced melanoma)
couldn’t be removed with surgery
cells didn’t have a change in the called BRAF
Cancer Research UK supported this trial.
Recruitment start: 20 April 2012
Recruitment end: 18 April 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Mark Middleton
Cancer Research UK
GlaxoSmithKline (GSK)
Novartis
University of Oxford
Last reviewed: 3 April 2019
CRUK internal database number: 8783
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
